Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study

Por McGready, R, Lee, SJ, Wiladphaingern, J, Ashley, EA, Rijken, MJ, Boel, M, Simpson, JA, Paw, MK, Pimanpanarak, M, Mu, Oh, Singhasivanon, P, White, NJ, Nosten, FH
Publicado em 2012

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria

Por Llanos-Cuentas, A., Lacerda, M.V.G., Hien, T.T., Vélez, I.D., Namaik-larp, C., Chu, C.S., Villegas, M.F., Val, F., Monteiro, W.M., Brito, M.A.M., Costa, M.R.F., Chuquiyauri, R., Casapía, M., Nguyen, C.H., Aruachan, S., Papwijitsil, R., Nosten, F.H., Bancone, G., Angus, B., Duparc, S., Craig, G., Rousell, V.M., Jones, S.W., Hardaker, E., Clover, D.D., Kendall, L., Mohamed, K., Koh, G.C.K.W., Wilches, V.M., Breton, J.J., Green, J.A.
Publicado no N Engl J Med (2019)